PREVENTIVE EFFECT OF ANTI-VIRAL THERAPY ON THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C OR B: A META-REGRESSION APPROACH

被引：0
|
作者：
Cheng, C. C. [1 ,2 ]
Shen, Y. C. [1 ,2 ,3 ]
Hsu, C. [1 ,3 ]
Hu, F. C. [1 ,2 ]
Cheng, A. L. [1 ,3 ,4 ]
机构：
[1] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60250-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [21] Hepatocellular carcinoma: clinical and radiological findings in patients with chronic B viral hepatitis and chronic C viral hepatitis
    Kim, Kyung Eun
    Park, Mi-Suk
    Bentley-Hibbert, Stuart
    Baek, Song-Ee
    Kim, Young Chul
    Kim, Myeong-Jin
    Kim, Ki Whang
    Auh, Yong H.
    ABDOMINAL IMAGING, 2012, 37 (04): : 591 - 594
  • [22] Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy-authors' reply
    Fan, Rong
    Hou, Jinlin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (05) : 724 - 725
  • [23] Cirrhosis Regression in Hepatitis C Patients With Sustained Virologic Response After Anti-Viral Therapy: A Meta-Analysis
    Saab, Sammy
    Manne, Vignan
    Akhtar, Ehsaan
    GASTROENTEROLOGY, 2014, 146 (05) : S970 - S970
  • [24] Factors associated with adherence to hepatocellular carcinoma surveillance in patients undergoing hepatitis B anti-viral therapy in Australia.
    Sheppard-Law, Suzanne
    Zablotska-Manos, Iryna
    Kermeen, Melissa
    Holdaway, Susan
    Lee, Alice
    Zekry, Amany
    George, Jacob
    Maher, Lisa
    HEPATOLOGY, 2016, 64 : 811A - 811A
  • [25] Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B
    Hsu, Yao-Chun
    Jun, Tomi
    Huang, Yen-Tsung
    Yeh, Ming-Lun
    Lee, Chia-Long
    Ogawa, Shintaro
    Cho, Shu-Hsien
    Lin, Jaw-Town
    Yu, Ming-Lung
    Nguyen, Mindie H.
    Tanaka, Yasuhito
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1128 - 1137
  • [26] REGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECT ANTI-VIRAL DRUGS
    Nwaezeigwe, Mary D.
    Kiat, Clifford
    Corbett, Susan
    Crosbie, Orla
    GASTROENTEROLOGY, 2018, 154 (06) : S1203 - S1203
  • [27] The impact of race on response to anti-viral therapy in patients with chronic hepatitis C.
    McHutchison, JG
    Poynard, T
    Gordon, SC
    Dienstag, J
    Morgan, T
    Yao, R
    Ling, MH
    Cort, S
    Garaud, JJ
    Albrecht, J
    HEPATOLOGY, 1999, 30 (04) : 302A - 302A
  • [28] Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy
    Buti, Maria
    Riveiro-Barciela, Mar
    Esteban, Rafael
    CLINICS IN LIVER DISEASE, 2021, 25 (04) : 725 - 740
  • [29] Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy
    Carreno, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (02) : 148 - 162
  • [30] Chronic hepatitis C - Genotypes and response to anti-viral therapy among Saudi patients
    Al-Traif, I
    Handoo, FA
    Al-Jumah, A
    Al-Nasser, M
    SAUDI MEDICAL JOURNAL, 2004, 25 (12) : 1935 - 1938
12345